LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 94.68 | 17.25 | 21 | 6239 | 0.0034 | 0.0234 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 94.68 | 17.25 | 9758 | 6239 | 1.5640 | 1.1081 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 94.68 | 17.25 | 1 | 6239 | 0.0002 | -0.2847 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 94.68 | 17.25 | 11235 | 6239 | 1.8007 | 1.1433 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 3.06 | 17.25 | 3 | 143 | 0.0209 | -0.4361 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 3.06 | 17.25 | 396 | 143 | 2.7651 | 1.7906 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 3.06 | 17.25 | 584 | 143 | 4.0778 | 2.1692 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 5.03 | 17.25 | 6 | 273 | 0.0219 | -0.2328 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 5.03 | 17.25 | 578 | 273 | 2.1144 | 1.4133 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 5.03 | 17.25 | 3 | 273 | 0.0110 | -0.3552 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 5.03 | 17.25 | 732 | 273 | 2.6778 | 1.5607 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 7.01 | 17.25 | 7 | 389 | 0.0180 | -0.1818 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 7.01 | 17.25 | 756 | 389 | 1.9409 | 1.3178 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 7.01 | 17.25 | 21 | 389 | 0.0539 | 0.0447 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 7.01 | 17.25 | 832 | 389 | 2.1361 | 1.3677 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 8.98 | 17.25 | 9 | 445 | 0.0202 | -0.1296 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 8.98 | 17.25 | 846 | 445 | 1.9008 | 1.2936 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 8.98 | 17.25 | 71 | 445 | 0.1595 | 0.3522 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 8.98 | 17.25 | 906 | 445 | 2.0356 | 1.3273 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 10.95 | 17.25 | 8 | 471 | 0.0170 | -0.1487 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 10.95 | 17.25 | 896 | 471 | 1.9000 | 1.2879 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 10.95 | 17.25 | 121 | 471 | 0.2566 | 0.5040 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 10.95 | 17.25 | 959 | 471 | 2.0336 | 1.3207 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 12.91 | 17.25 | 5 | 494 | 0.0101 | -0.2257 | MN20160310_N02 | K22 |